+319.1%
DDOG vs MRNA
+1,001.1%
-682.0%
-68.1%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | -5.5% | -2.2% | -3.3% | -5.3% |
| 7D | -14.5% | -12.7% | -1.8% | -13.7% |
| 30D | -42.4% | -20.7% | -21.7% | -41.6% |
| 3M | -32.3% | +46.3% | -78.6% | -34.5% |
| 6M | -25.9% | +305.2% | -331.1% | -39.7% |
| YTD | +15.7% | +561.2% | -545.5% | -13.9% |
| 1Y | -1.4% | +772.1% | -773.5% | -30.0% |
| 3Y | +40.8% | +147.0% | -106.2% | +14.6% |
| 5Y | -18.3% | -26.1% | +7.8% | -24.7% |
| All | +319.1% | +1,001.1% | -682.0% | +315.7% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling